Sign In
Buy ONTTF
$1.90
+0 (+0%)
At Close: Jun 03, 2026
Oxford Nanopore soars as Novo Nordisk builds stake
04:14am, Thursday, 01'st Aug 2024
Oxford Nanopore Technologies PLC (LSE:ONT), the London-listed tech group, has rallied close to 12% this morning after it was revealed drug giant Novo Nordisk (NYSE:NVO) had bought a £50 million stake
Oxford Nanopore Technologies and Plasmidsaurus Announce Strategic Collaboration to Advance Plasmid Sequencing
10:12am, Tuesday, 23'rd Jul 2024
OXFORD, England, & LOS ANGELES--(BUSINESS WIRE)-- #Nanopore--Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, and Plasmidsaurus, th
Oxford Nanopore Technologies (ONT) - Product Pipeline Analysis 2024
04:36am, Thursday, 06'th Jun 2024
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Oxford Nanopore Technologies Plc (ONT) - Product Pipeline Analysis, 2024 Update" company profile has been added to ResearchAndMarkets.com's offering. Oxf
Oxford Nanopore Technologies and SeqOne Partner to Support Interpretation of Nanopore Sequencing in Clinical Use
06:36am, Monday, 11'th Mar 2024
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and SeqOne, the leading AI
Oxford Nanopore launches PromethION 2 Integrated into open early access
10:16am, Thursday, 07'th Mar 2024
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies today announced the early access launch of its all-in-one desk top sequencing device, the PromethION 2 Integrated (P2i) to complete its P
Oxford Nanopore Technologies plc (ONTTF) Full Year 2023 Earnings Call Transcript
07:50pm, Wednesday, 06'th Mar 2024
Oxford Nanopore Technologies plc (OTCPK:ONTTF) FY2023 Earnings Conference Call March 6, 2024 7:00 AM ET Company Participants Gordon Sanghera - Chief Executive Officer Nick Keher - Chief Financial Offi
Britain's Oxford Nanopore's shares sink after revenue warning
06:01am, Tuesday, 09'th Jan 2024
Shares in Britain's Oxford Nanopore dropped nearly 12% on Tuesday, after the sensing technology company issued a revenue warning, citing a slowdown in China and the Middle East, along with staggered p
Oxford Nanopore sales hit by US semiconductor restrictions
03:18am, Tuesday, 09'th Jan 2024
Oxford Nanopore Technologies said it had seen disruption to its diagnostics businesses due to the US/China trade war and second-half sales growth was slower than expected in some areas Over 2023, r
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies (Oxford Nanopore) and WeNou, a company providing innovative services based on DNA analysis for the food and feed sectors, today announce
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore), the nanopore-sequencing company delivering unparalleled rich genomic data insights, and Fabric Genomics, the leadi
OXFORD, United Kingdom--(BUSINESS WIRE)-- #genomics--Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and Sap
Oxford Nanopore gets £70m investment from French in-vitro diagnostics partner
03:05am, Thursday, 19'th Oct 2023
Oxford Nanopore Technologies PLC (LSE:ONT) has secured a £70 million investment from French in-vitro diagnostics (IVD) company bioMérieux, in exchange for a 3.5% stake. Family-owned bioMérieux said
Mayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disorders
02:00am, Thursday, 19'th Oct 2023
ROCHESTER, Minn. & OXFORD, England--(BUSINESS WIRE)--Mayo Clinic and Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today unveile
OXFORD, England & BRISBANE, Australia--(BUSINESS WIRE)--Researchers at The University of Queensland are harnessing the latest sequencing technology developed by UK-based biotech Oxford Nanopore Techno
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore sequencing technology has been used by a team led by researchers at the National Institutes of Health Center for Alzheimer's and Related Dementias (CA
